Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein disulfide-isomerase (PDI) is a multifunctional enzyme and chaperone in the endoplasmic reticulum that catalyzes the formation, rearrangement, and reduction of disulfide bonds during the folding of secretory and membrane proteins; it plays key roles in ER protein quality control, antigen presentation, and the unfolded protein response[1][3][4][5]. Heat shock proteins (HSPs) are a large family of molecular chaperones that stabilize, refold, and prevent aggregation of misfolded proteins under stress conditions, participating in cell survival, immunity, inflammation, and disease modulation[5][7][10].
PDI inhibitors: Inhibit disulfide bond formation/isomerization, disrupt protein folding, induce ER stress/apoptosis. HSP inhibitors: Block chaperone function, destabilize oncogenic client proteins, modulate immune response, induce apoptosis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Disulfide Isomerases & Heat Shock Proteins.